Pharma industry is boosting Swiss exports
Share this article
Pharma products take first place on the Swiss export board
The high demande from international markets drives Swiss pharma products to represent 50% of total exports. The industry remains ahead as a result of the continuous implementation of high level innovation.
2019’s second quarter has seen Swiss foreign trade grow by 1,4% according to results published by the Federal Customs Administration (FCA). Exports have reached a record of 58,25 billion Swiss francs, most of which originates from the pharma industry.